Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia, Pneumococcal | 6 | 2019 | 126 | 1.740 |
Why?
|
| Gelsolin | 3 | 2019 | 190 | 1.300 |
Why?
|
| Macrophages, Alveolar | 7 | 2017 | 407 | 1.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2015 | 689 | 0.820 |
Why?
|
| Immunologic Factors | 2 | 2019 | 1575 | 0.430 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2723 | 0.220 |
Why?
|
| Immunity, Innate | 2 | 2014 | 2956 | 0.220 |
Why?
|
| Lung | 5 | 2023 | 9826 | 0.200 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2023 | 274 | 0.190 |
Why?
|
| Phagocytosis | 4 | 2015 | 1538 | 0.190 |
Why?
|
| Receptors, Immunologic | 3 | 2017 | 1423 | 0.180 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 6608 | 0.150 |
Why?
|
| Streptococcus pneumoniae | 3 | 2015 | 712 | 0.150 |
Why?
|
| Receptors, Scavenger | 1 | 2017 | 121 | 0.140 |
Why?
|
| Muromonab-CD3 | 1 | 2016 | 96 | 0.140 |
Why?
|
| Maternal Exposure | 2 | 2017 | 961 | 0.140 |
Why?
|
| Air Pollutants | 4 | 2017 | 2814 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 733 | 0.130 |
Why?
|
| Francisella tularensis | 1 | 2015 | 56 | 0.130 |
Why?
|
| Benzodioxoles | 1 | 2014 | 69 | 0.120 |
Why?
|
| Asthma | 3 | 2023 | 5955 | 0.120 |
Why?
|
| Indans | 1 | 2014 | 96 | 0.120 |
Why?
|
| Microbial Viability | 1 | 2014 | 234 | 0.110 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2015 | 248 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2023 | 1472 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2014 | 558 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2017 | 21821 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 457 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1200 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 834 | 0.090 |
Why?
|
| Titanium | 3 | 2007 | 494 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18006 | 0.090 |
Why?
|
| Actins | 1 | 2017 | 2120 | 0.090 |
Why?
|
| Mice | 10 | 2023 | 81045 | 0.080 |
Why?
|
| Astrocytes | 1 | 2016 | 1266 | 0.080 |
Why?
|
| Vehicle Emissions | 2 | 2017 | 665 | 0.080 |
Why?
|
| Weight Loss | 1 | 2019 | 2604 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2015 | 1780 | 0.080 |
Why?
|
| Animals | 12 | 2023 | 168561 | 0.080 |
Why?
|
| Estrogens | 1 | 2014 | 1562 | 0.070 |
Why?
|
| Neutrophil Activation | 2 | 2007 | 186 | 0.070 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2007 | 118 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 10248 | 0.070 |
Why?
|
| Particulate Matter | 2 | 2007 | 2523 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2007 | 455 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 766 | 0.060 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2015 | 4214 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2023 | 114 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 2986 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2023 | 424 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9846 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14554 | 0.050 |
Why?
|
| Proline | 1 | 2023 | 458 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2003 | 689 | 0.050 |
Why?
|
| Cell Line | 1 | 2015 | 15994 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3239 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2023 | 1034 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3199 | 0.040 |
Why?
|
| Antigens | 1 | 2023 | 1462 | 0.040 |
Why?
|
| Inflammation | 2 | 2015 | 10578 | 0.040 |
Why?
|
| Male | 6 | 2019 | 349538 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2014 | 21719 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2017 | 273 | 0.040 |
Why?
|
| HIV Infections | 1 | 2023 | 16678 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2017 | 719 | 0.030 |
Why?
|
| Neutrophils | 2 | 2007 | 3711 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2017 | 389 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 446 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10232 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6382 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 62966 | 0.030 |
Why?
|
| Inhalation Exposure | 2 | 2007 | 443 | 0.030 |
Why?
|
| Eosinophils | 1 | 2017 | 953 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4414 | 0.030 |
Why?
|
| Lung Injury | 1 | 2017 | 436 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1875 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3678 | 0.020 |
Why?
|
| Particle Size | 2 | 2007 | 1640 | 0.020 |
Why?
|
| Protein Binding | 2 | 2017 | 9387 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 57683 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 56350 | 0.020 |
Why?
|
| Cytokines | 3 | 2007 | 7317 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 85649 | 0.020 |
Why?
|
| Bacteria | 1 | 2017 | 2102 | 0.020 |
Why?
|
| Female | 5 | 2017 | 379592 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2723 | 0.020 |
Why?
|
| Cities | 1 | 2007 | 511 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2007 | 390 | 0.020 |
Why?
|
| Aerosols | 1 | 2007 | 623 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2007 | 3081 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2004 | 120 | 0.020 |
Why?
|
| Oxidants | 1 | 2003 | 164 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4282 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1791 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 162944 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 213712 | 0.010 |
Why?
|
| Pregnancy | 2 | 2017 | 29087 | 0.010 |
Why?
|
| Humans | 6 | 2023 | 742088 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 213127 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 1341 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 2077 | 0.010 |
Why?
|
| Metals | 1 | 2003 | 717 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 1638 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 3847 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3862 | 0.010 |
Why?
|
| Antioxidants | 1 | 2003 | 1659 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 5872 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3444 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 7790 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5975 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4553 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 13029 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9735 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9410 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 5655 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12071 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19223 | 0.000 |
Why?
|
| Rats | 1 | 2003 | 24265 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 16665 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 40054 | 0.000 |
Why?
|
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_